Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells, especially injected into the skin, heal wounds faster and better than chitosan gel or other treatments.

Msx2 deficiency in mice leads to bone growth and organ development problems.

Testosterone therapy increases bone density in older men with low testosterone levels.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Blood vessels and specific genes help turn cartilage into bone when bones heal.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

BMP signaling controls hair follicle size and cell growth by affecting cell cycle genes.

Coats' Plus is a genetic disorder with eye abnormalities, brain calcification, poor growth, bone and skin issues, and movement disorders.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Stretching skin increases a certain protein that attracts stem cells, helping skin regeneration.

Bone marrow and umbilical cord stem cells can help grow new hair.

Blocking a specific protein signal can make hair grow on mouse nipples.

GLI2 increases follistatin production in human skin cells.

Finasteride doesn't affect bone density in male rats.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

Balding men had lower bone density, while balding women had higher hip bone density.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The hairline lowering surgery with bone tunneling suture fixation is safe and effective, with high patient satisfaction.